Magnetic resonance imaging in vascular biology

Artery Research

Volumn 2, Issue 1, 2008, Pages 9-20

  Voehringer, Matthias ^a,b   Sechtem, Udo ^b   Friedrich, Matthias G ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Atherosclerosis; Imaging; Magnetic resonance imaging; Vessels

Indexed keywords

ANGIOGENESIS; ARTERIAL STIFFNESS; ARTERY ENDOTHELIUM; ARTERY OCCLUSION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; HUMAN; INTRAVASCULAR ULTRASOUND; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND; X RAY;

EID: 40049112433     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2008.01.002     Document Type: Review

References (84)

1. Verma S., and Anderson T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation 105 (2002) 546-549
2. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
3. Sorensen M.B., Collins P., Ong P.J., Webb C.M., Hayward C.S., Asbury E.A., et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 106 (2002) 1646-1651
4. Mitchell G.F., Parise H., Vita J.A., Larson M.G., Warner E., Keaney Jr. J.F., et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart study. Hypertension 44 (2004) 134-139
5. Silber H.A., Ouyang P., Bluemke D.A., Gupta S.N., Foo T.K., and Lima J.A. A novel method for assessing arterial endothelial function using phase contrast magnetic resonance imaging: vasoconstriction during reduced shear. J Cardiovasc Magn Reson 7 (2005) 615-621
6. Silber H.A., Bluemke D.A., Ouyang P., Du Y.P., Post W.S., and Lima J.A. The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography. J Am Coll Cardiol 38 (2001) 1859-1865
7. Silber H.A., Ouyang P., Bluemke D.A., Gupta S.N., Foo T.K., and Lima J.A. Why is flow-mediated dilation dependent on arterial size? Assessment of the shear stimulus using phase-contrast magnetic resonance imaging. Am J Physiol Heart Circ Physiol 288 (2005) H822-H828
8. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
9. Oelhafen M., Schwitter J., Kozerke S., Luechinger R., and Boesiger P. Assessing arterial blood flow and vessel area variations using real-time zonal phase-contrast MRI. J Magn Reson Imaging 23 (2006) 422-429
10. Schwitter J., Oelhafen M., Wyss B.M., Kozerke S., Amann-Vesti B., Luscher T.F., et al. 2D-spatially-selective real-time magnetic resonance imaging for the assessment of microvascular function and its relation to the cardiovascular risk profile. J Cardiovasc Magn Reson 8 (2006) 759-769
11. Wiesmann F., Petersen S.E., Leeson P.M., Francis J.M., Robson M.D., Wang Q., et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol 44 (2004) 2056-2064
12. Anderson T.J. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol 22 Suppl. B (2006) B72-B80
13. Terashima M., Meyer C.H., Keeffe B.G., Putz E.J., de la Pena-Almaguer E., Yang P.C., et al. Noninvasive assessment of coronary vasodilation using magnetic resonance angiography. J Am Coll Cardiol 45 (2005) 104-110
14. Ogawa S., Tank D.W., Menon R., Ellermann J.M., Kim S.G., Merkle H., et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A 89 (1992) 5951-5955
15. Utz W., Jordan J., Niendorf T., Stoffels M., Luft F.C., Dietz R., et al. Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Arterioscler Thromb Vasc Biol 25 (2005) 1408-1413
16. Friedrich M.G., Niendorf T., Schulz-Menger J., Gross C.M., and Dietz R. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation 108 (2003) 2219-2223
17. Mohiaddin R.H., Underwood S.R., Bogren H.G., Firmin D.N., Klipstein R.H., Rees R.S., et al. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J 62 (1989) 90-96
18. Mohiaddin R.H., Firmin D.N., and Longmore D.B. Age-related changes of human aortic flow wave velocity measured noninvasively by magnetic resonance imaging. J Appl Physiol 74 (1993) 492-497
19. Resnick L.M., Militianu D., Cunnings A.J., Pipe J.G., Evelhoch J.L., and Soulen R.L. Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 30 (1997) 654-659
20. Rogers W.J., Hu Y.L., Coast D., Vido D.A., Kramer C.M., Pyeritz R.E., et al. Age-associated changes in regional aortic pulse wave velocity. J Am Coll Cardiol 38 (2001) 1123-1129
21. Yu H.Y., Peng H.H., Wang J.L., Wen C.Y., and Tseng W.Y. Quantification of the pulse wave velocity of the descending aorta using axial velocity profiles from phase-contrast magnetic resonance imaging. Magn Reson Med 56 (2006) 876-883
22. Blankenhorn D.H., and Curry P.J. The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement. A review. Arch Pathol Lab Med 106 (1982) 483-489
23. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
24. Pasterkamp G., Galis Z.S., and de Kleijn D.P. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 24 (2004) 650-657
25. Saito D., Oka T., Kajiyama A., Ohnishi N., and Shiraki T. Factors predicting compensatory vascular remodelling of the carotid artery affected by atherosclerosis. Heart 87 (2002) 136-139
26. Kaneko E., Skinner M.P., Raines E.W., Yuan C., Rosenfeld M.E., Wight T.N., et al. Detection of dissection and remodeling of atherosclerotic lesions in rabbits after balloon angioplasty by magnetic-resonance imaging. Coron Artery Dis 11 (2000) 599-606
27. Worthley S.G., Helft G., Fuster V., Zaman A.G., Fayad Z.A., Fallon J.T., et al. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 101 (2000) 586-589
28. Hegyi L., Hockings P.D., Benson M.G., Busza A.L., Overend P., Grimsditch D.C., et al. Short term arterial remodelling in the aortae of cholesterol fed New Zealand white rabbits shown in vivo by high-resolution magnetic resonance imaging - implications for human pathology. Pathol Oncol Res 10 (2004) 159-165
29. Yuan C., Beach K.W., Smith Jr. L.H., and Hatsukami T.S. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 98 (1998) 2666-2671
30. Kim W.Y., Stuber M., Bornert P., Kissinger K.V., Manning W.J., and Botnar R.M. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106 (2002) 296-299
31. Fleiner M., Kummer M., Mirlacher M., Sauter G., Cathomas G., Krapf R., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110 (2004) 2843-2850
32. Moreno P.R., Purushothaman K.R., Fuster V., Echeverri D., Truszczynska H., Sharma S.K., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110 (2004) 2032-2038
33. Moulton K.S. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol 17 (2006) 548-555
34. Yuan C., Kerwin W.S., Ferguson M.S., Polissar N., Zhang S., Cai J., et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 15 (2002) 62-67
35. Kerwin W., Hooker A., Spilker M., Vicini P., Ferguson M., Hatsukami T., et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107 (2003) 851-856
36. O'Connor J.P., Jackson A., Parker G.J., and Jayson G.C. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96 (2007) 189-195
37. Virmani R., Kolodgie F.D., Burke A.P., Finn A.V., Gold H.K., Tulenko T.N., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005) 2054-2061
38. Takaya N., Yuan C., Chu B., Saam T., Polissar N.L., Jarvik G.P., et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111 (2005) 2768-2775
39. Winter P.M., Morawski A.M., Caruthers S.D., Fuhrhop R.W., Zhang H., Williams T.A., et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 108 (2003) 2270-2274
40. Winter P.M., Neubauer A.M., Caruthers S.D., Harris T.D., Robertson J.D., Williams T.A., et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 26 (2006) 2103-2109
41. Cai W., and Chen X. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med Chem 6 (2006) 407-428
42. Zhang C., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 67 (2007) 1555-1562
43. Nederkoorn P.J., van der Graaf Y., and Hunink M.G. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 34 (2003) 1324-1332
44. Koelemay M.J., Lijmer J.G., Stoker J., Legemate D.A., and Bossuyt P.M. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 285 (2001) 1338-1345
45. Sommerville R.S., Jenkins J., Walker P., and Olivotto R. 3-D magnetic resonance angiography versus conventional angiography in peripheral arterial disease: pilot study. ANZ J Surg 75 (2005) 373-377
46. Tan K.T., van Beek E.J., Brown P.W., van Delden O.M., Tijssen J., and Ramsay L.E. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 57 (2002) 617-624
47. Vasbinder G.B., Nelemans P.J., Kessels A.G., Kroon A.A., Maki J.H., Leiner T., et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 141 (2004) 674-682 discussion 682
48. Nael K., Ruehm S.G., Michaely H.J., Saleh R., Lee M., Laub G., et al. Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol 188 (2007) 529-539
49. Kim W.Y., Danias P.G., Stuber M., Flamm S.D., Plein S., Nagel E., et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345 (2001) 1863-1869
50. Sakuma H., Ichikawa Y., Suzawa N., Hirano T., Makino K., Koyama N., et al. Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography. Radiology 237 (2005) 316-321
51. Paetsch I., Jahnke C., Barkhausen J., Spuentrup E., Cavagna F., Schnackenburg B., et al. Detection of coronary stenoses with contrast enhanced, three-dimensional free breathing coronary MR angiography using the gadolinium-based intravascular contrast agent gadocoletic acid (B-22956). J Cardiovasc Magn Reson 8 (2006) 509-516
52. Metz L.D., Beattie M., Hom R., Redberg R.F., Grady D., and Fleischmann K.E. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 49 (2007) 227-237
53. Schuijf J.D., Wijns W., Jukema J.W., Atsma D.E., de Roos A., Lamb H.J., et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 48 (2006) 2508-2514
54. Tracy R.E., Devaney K., and Kissling G. Characteristics of the plaque under a coronary thrombus. Virchows Arch A Pathol Anat Histopathol 405 (1985) 411-427
55. Falk E. Why do plaques rupture?. Circulation 86 (1992) III30-III42
56. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., and Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 94 (1996) 932-938
57. Hatsukami T.S., Ross R., Polissar N.L., and Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102 (2000) 959-964
58. Yuan C., Mitsumori L.M., Ferguson M.S., Polissar N.L., Echelard D., Ortiz G., et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104 (2001) 2051-2056
59. Saam T., Kerwin W.S., Chu B., Cai J., Kampschulte A., Hatsukami T.S., et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 7 (2005) 799-808
60. Trivedi R.A., JM UK-I, Graves M.J., Horsley J., Goddard M., Kirkpatrick P.J., et al. MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46 (2004) 738-743
61. Cai J., Hatsukami T.S., Ferguson M.S., Kerwin W.S., Saam T., Chu B., et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112 (2005) 3437-3444
62. Fayad Z.A., Nahar T., Fallon J.T., Goldman M., Aguinaldo J.G., Badimon J.J., et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 101 (2000) 2503-2509
63. Botnar R.M., Stuber M., Kissinger K.V., Kim W.Y., Spuentrup E., and Manning W.J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 102 (2000) 2582-2587
64. Yarnykh V.L., Terashima M., Hayes C.E., Shimakawa A., Takaya N., Nguyen P.K., et al. Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging 23 (2006) 691-698
65. Viereck J., Ruberg F.L., Qiao Y., Perez A.S., Detwiller K., Johnstone M., et al. MRI of atherothrombosis associated with plaque rupture. Arterioscler Thromb Vasc Biol 25 (2005) 240-245
66. Barkhausen J., Ebert W., Heyer C., Debatin J.F., and Weinmann H.J. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation 108 (2003) 605-609
67. McConnell M.V., Aikawa M., Maier S.E., Ganz P., Libby P., and Lee R.T. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 19 (1999) 1956-1959
68. Helft G., Worthley S.G., Fuster V., Fayad Z.A., Zaman A.G., Corti R., et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 105 (2002) 993-998
69. Corti R., Osende J.I., Fallon J.T., Fuster V., Mizsei G., Jneid H., et al. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 464-473
70. Zhao X.Q., Yuan C., Hatsukami T.S., Frechette E.H., Kang X.J., Maravilla K.R., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 21 (2001) 1623-1629
71. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Smith D., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
72. Yonemura A., Momiyama Y., Fayad Z.A., Ayaori M., Ohmori R., Higashi K., et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 45 (2005) 733-742
73. Saam T., Ferguson M.S., Yarnykh V.L., Takaya N., Xu D., Polissar N.L., et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 25 (2005) 234-239
74. Yuan C., Zhang S.X., Polissar N.L., Echelard D., Ortiz G., Davis J.W., et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 105 (2002) 181-185
75. Takaya N., Yuan C., Chu B., Saam T., Underhill H., Cai J., et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 37 (2006) 818-823
76. Kampschulte A., Ferguson M.S., Kerwin W.S., Polissar N.L., Chu B., Saam T., et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110 (2004) 3239-3244
77. Kooi M.E., Cappendijk V.C., Cleutjens K.B., Kessels A.G., Kitslaar P.J., Borgers M., et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107 (2003) 2453-2458
78. Trivedi R.A., JM UK-I, Graves M.J., Cross J.J., Horsley J., Goddard M.J., et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35 (2004) 1631-1635
79. Trivedi R.A., Mallawarachi C., JM UK-I, Graves M.J., Horsley J., Goddard M.J., et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 26 (2006) 1601-1606
80. Frias J.C., Williams K.J., Fisher E.A., and Fayad Z.A. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 126 (2004) 16316-16317
81. Botnar R.M., Buecker A., Wiethoff A.J., Parsons Jr. E.C., Katoh M., Katsimaglis G., et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 110 (2004) 1463-1466
82. Querol M., Chen J.W., and Bogdanov Jr. A.A. A paramagnetic contrast agent with myeloperoxidase-sensing properties. Org Biomol Chem 4 (2006) 1887-1895
83. Sirol M., Aguinaldo J.G., Graham P.B., Weisskoff R., Lauffer R., Mizsei G., et al. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis 182 (2005) 79-85
84. Jaffer F.A., Libby P., and Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47 (2006) 1328-1338